KNSA - Kiniksa Pharmaceuticals International, plc
46.02
-1.250 -2.716%
Share volume: 729,576
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$47.27
-1.25
-0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 04-25-2024 | 07-25-2024 | 10-29-2024 | 02-25-2025 | 04-29-2025 | 07-29-2025 | 10-28-2025 | 02-24-2026 | |
| Assets | |||||||||
| Total Assets | 519.673 M | 542.428 M | 555.298 M | 580.553 M | 599.326 M | 661.150 M | 712.333 M | 763.633 M | |
| Current Assets | 270.591 M | 301.021 M | 311.301 M | 331.799 M | 355.907 M | 420.311 M | 475.530 M | 527.177 M | |
| Inventories | 27.278 M | 34.858 M | 28.680 M | 26.364 M | 22.069 M | 48.181 M | 41.396 M | 54.895 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 72.474 M | 119.487 M | 126.404 M | 60.046 M | 111.208 M | 115.745 M | 177.244 M | 248.478 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 141.078 M | 99.271 M | 97.376 M | 183.581 M | 157.132 M | 192.037 M | 174.858 M | 165.596 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 712.000 K | 625.000 K | 561.000 K | 662.000 K | 606.000 K | 1.076 M | 1.655 M | 1.943 M | |
| Other Assets | 248.370 M | 240.782 M | 243.436 M | 248.092 M | 242.813 M | 239.763 M | 235.148 M | 234.513 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 519.673 M | 542.428 M | 555.298 M | 580.553 M | 599.326 M | 661.150 M | 712.333 M | 763.633 M | |
| Total liabilities | 87.778 M | 107.333 M | 118.292 M | 142.117 M | 141.837 M | 166.143 M | 176.950 M | 196.027 M | |
| Total current liabilities | 64.212 M | 84.291 M | 95.955 M | 100.621 M | 97.267 M | 117.827 M | 123.592 M | 139.184 M | |
| Accounts Payable | 5.632 M | 7.393 M | 8.328 M | 2.039 M | 1.982 M | 8.956 M | 6.150 M | 2.028 M | |
| Other liabilities | 11.755 M | 11.243 M | 10.526 M | 9.685 M | 12.759 M | 16.505 M | 21.547 M | 25.032 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 11.755 M | 11.243 M | 10.526 M | 9.685 M | 12.759 M | 16.505 M | 21.547 M | 25.032 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 431.895 M | 435.095 M | 437.006 M | 438.436 M | 457.489 M | 495.007 M | 535.383 M | 567.606 M | |
| Common stock | 927.602 M | 934.787 M | 949.302 M | 959.742 M | 970.258 M | 989.832 M | 1.012 B | 1.030 B | |
| Retained earnings | -495.654 M | -499.562 M | -512.255 M | -521.143 M | -512.604 M | -494.772 M | -476.337 M | -462.138 M |